These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25690567)

  • 1. Bencycloquidium bromide inhibits nasal hypersecretion in a rat model of allergic rhinitis.
    Long R; Zhou Y; Huang J; Peng L; Meng L; Zhu S; Li J
    Inflamm Res; 2015 Apr; 64(3-4):213-23. PubMed ID: 25690567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M(3) muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice.
    Cao R; Dong XW; Jiang JX; Yan XF; He JS; Deng YM; Li FF; Bao MJ; Xie YC; Chen XP; Xie QM
    Eur J Pharmacol; 2011 Mar; 655(1-3):83-90. PubMed ID: 21277298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saikosaponin A ameliorates nasal inflammation by suppressing IL-6/ROR-γt/STAT3/IL-17/NF-κB pathway in OVA-induced allergic rhinitis.
    Piao CH; Song CH; Lee EJ; Chai OH
    Chem Biol Interact; 2020 Jan; 315():108874. PubMed ID: 31669322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin 5 subtype AC expression and upregulation in the nasal mucosa of allergic rhinitis rats.
    Wang W; Zheng M
    Otolaryngol Head Neck Surg; 2012 Dec; 147(6):1012-9. PubMed ID: 22972875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release.
    Bui TT; Piao CH; Song CH; Chai OH
    Int Immunopharmacol; 2017 Nov; 52():77-84. PubMed ID: 28886581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of baicalin on allergic response in ovalbumin-induced allergic rhinitis guinea pigs and lipopolysaccharide-stimulated human mast cells.
    Zhou YJ; Wang H; Sui HH; Li L; Zhou CL; Huang JJ
    Inflamm Res; 2016 Aug; 65(8):603-12. PubMed ID: 27043920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
    Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
    Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, safety and tolerability of Bencycloquidium bromide, a novel selective muscarinic M1/M3 receptor antagonist, after single and multiple intranasal doses in healthy chinese subjects: an open-label, single-center, first-in-human study.
    Sun L; Ding L; Wang Y; Zhou W; Yan Z; Sun W; Zhang H; Ou N; Chen X
    Drugs R D; 2012 Mar; 12(1):17-28. PubMed ID: 22339483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gleditsia sinensis Lam. aqueous extract attenuates nasal inflammation in allergic rhinitis by inhibiting MUC5AC production through suppression of the STAT3/STAT6 pathway.
    Jung MA; Song HK; Jo K; Lee A; Hwang YH; Ji KY; Jung DH; Cai M; Lee JY; Pyun BJ; Kim T
    Biomed Pharmacother; 2023 May; 161():114482. PubMed ID: 36921533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bencycloquidium bromide nasal spray is effective and safe for persistent allergic rhinitis: a phase III, multicenter, randomized, double-blinded, placebo-controlled clinical trial.
    Jiang Z; Xiao H; Liu S; He G; Hu G; Zhang X; Zhang Q; Chen J; Lin C; Liang J; Guo M; Xiao X; Xue W; Dong P; Huang Y; Lian Z; Tan G; He J; Pan Y; Meng J
    Eur Arch Otorhinolaryngol; 2020 Nov; 277(11):3067-3077. PubMed ID: 32623510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 attenuates murine allergic rhinitis by downregulated HMGB 1/TLR4 pathway.
    Yuan Y; Liu Q; Zhao J; Tang H; Sun J
    Scand J Immunol; 2018 Jun; 87(6):e12667. PubMed ID: 29701897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-31 attenuates murine allergic rhinitis by suppressing interleukin-13-induced nasal epithelial inflammatory responses.
    Zhou F; Liu P; Lv H; Gao Z; Chang W; Xu Y
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Yupingfeng granule on cytokines of allergic rhinitis induced by OVA in rats].
    Tong L; Liu JL; Wang JX; Sun LL; Song YL; Tian GY; He S; Gao YJ
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):728-730. PubMed ID: 28871701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect and mechanism of IL-1β/JNK transduction pathway on the nasal mucosa remodeling in allergic rhinitis rats].
    Gu X; Li Q; Chen Y; Ma Y; Zhang Y; Sun C; You C
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb; 30(3):226-9. PubMed ID: 27373094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Benzo[α]pyrene on Mucus Secretion and Tissue Remodeling in a Rat Model of Allergic Rhinitis.
    Liu J; Chen G; Qin X; Sun Q; Guo Z
    Ann Otol Rhinol Laryngol; 2024 Oct; 133(10):886-892. PubMed ID: 39148236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a Chinese herbal formula, Shi-Bi-Lin, on an experimental model of allergic rhinitis.
    Zhao Y; van Hasselt CA; Woo JK; Chen GG; Wong YO; Wang LH; Leung PC
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):844-50. PubMed ID: 16802773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+ -activated K+ channel-3.1 blocker TRAM-34 alleviates murine allergic rhinitis.
    Lin H; Zheng C; Li J; Yang C; Hu L
    Int Immunopharmacol; 2014 Dec; 23(2):642-8. PubMed ID: 25466273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin attenuates allergic inflammation by blocking prostaglandin biosynthesis in rats with allergic rhinitis.
    Dong L; Wen S; Tang Y; Li F; He Y; Deng Y; Tao Z
    Int Immunopharmacol; 2023 Feb; 115():109681. PubMed ID: 36634416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent ameliorating effect of Hypoxia-inducible factor 1α (HIF-1α) antagonist YC-1 on combined allergic rhinitis and asthma syndrome (CARAS) in Rats.
    Wang X; Liu C; Wu L; Zhu S
    Eur J Pharmacol; 2016 Oct; 788():343-350. PubMed ID: 27498367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental studies for botulinum toxin type A to antagonist the VIP/PACAP expression on nasal mucosa in allergic rhinitis rat].
    Liu L; Wang B; Liang G; Lu L; Yang L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(1):49-53. PubMed ID: 27197456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.